News
In recent years, Novogene Europe has systematically integrated state-of-the-art technologies across its service portfolio, ...
Dr Lal PathLabs has expanded its genomics capabilities by adding Illumina’s NovaSeq X Series to its dedicated genomics division, Genevolve. With the integration of Illumina’s latest technology, DLPL ...
Illumina, Inc. (NASDAQ: ILMN) announced it has entered into a definitive agreement with Standard BioTools (NASDAQ: LAB) under which Illumina will acquire SomaLogic, a leader in data-driven ...
Element Bio’s bid to take on Illumina in the DNA sequencing market has been helped by an impressive $277m financing round.
This transaction builds on a co-development agreement Illumina established with SomaLogic in December 2021 to bring the SomaScan® Proteomics Assay onto Illumina's high-throughput ...
Combines highly complementary proteomics expertise with Illumina's industry-leading product innovation and global market reach ...
This transaction builds on a co-development agreement Illumina established with SomaLogic in December 2021 to bring the SomaScan® Proteomics Assay onto Illumina's high-throughput ...
In 2007, the next-generation sequencing technologies have come into their own with an impressive array of successful applications. Kelly Rae Chi reports.
Hosted on MSN18d
Standard BioTools jumps on sale of SomaLogic to Illumina - MSNStandard BioTools (NASDAQ: LAB) shares jumped as much as 19% premarket on Monday after the company announced the sale of its SomaLogic business to Illumina (NASDAQ: ILMN) for an aggregate cash ...
Uzbekistan has made significant progress in its transition to a market economy since 2017, achieving advancements in macroeconomic stabilization, trade and exchange rate liberalization, price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results